Jack Clark
AssayQuant Awarded NIA SBIR for Neurodegeneration Kinase Assays
MARLBOROUGH, Mass., October 2026 — AssayQuant Technologies, Inc. has been awarded a Direct-to-Phase...
2 minute read
Covalent Inhibitor Profiling: kinact/KI, Selectivity & Residence Time
Covalent inhibitors have changed how scientists approach kinase-targeted therapies. Unlike...
6 minute read